Engineered Subcutaneous Site for Optimal Organoid Transplantation

Engineering ›› DOI: 10.1016/j.eng.2025.10.016

review-article

Author information +

History +

PDF (9738KB)

Abstract

The subcutaneous space is an advantageous site for cell transplantation because of its minimally invasive accessibility. However, poor vascularization often compromises cell survival, leading to significant apoptosis of transplanted cells. To address this limitation, we engineered a pre-vascularized niche by subcutaneously implanting polyvinyl chloride (PVC) catheters into rodent models. Foreign body reactions elicited by PVC catheters recruited reparative immune cells, which secreted pro-angiogenic factors to induce robust neovascularization. The subsequent transplantation of stem cell-derived vascular organoids into this engineered niche resulted in optimal engraftment, forming functional, perfused human blood vessels. In a proof-of-concept islet transplantation model, even a marginal dose of islets rapidly restored normoglycemia, which was attributed to enhanced graft revascularization. Collectively, our findings demonstrate a simple yet effective strategy for overcoming the vascular limitations of subcutaneous cell transplantation, offering promising potential for clinical applications.

Keywords

Subcutaneous / Pre-vascularization / Vascular organoid / Islet transplantation

Cite this article

Download citation ▾

Dayan Li, Xinyue Zhao, Weijing Kong, Lijun Sun, Changqi Xiao, Zihang Pan, Qiyang Yao, Jiahua Zheng, Guoheng Xu, Xi Wang, Kai Wang. Engineered Subcutaneous Site for Optimal Organoid Transplantation. Engineering DOI:10.1016/j.eng.2025.10.016

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Novosel EC, Kleinhans C, Kluger PJ.Vascularization is the key challenge in tissue engineering.Adv Drug Deliv Rev 2011; 63(4–5):300-311.

[2]	Wang K, Wang X, Han C, Chen L, Luo Y.Scaffold-supported transplantation of islets in the epididymal fat pad of diabetic mice.J Vis Exp 2017; 125:54995.

[3]	Bowers DT, Song W, Wang LH, Ma M.Engineering the vasculature for islet transplantation.Acta Biomater 2019; 95:131-151.

[4]	Vlahos AE, Talior-Volodarsky I, Kinney SM, Sefton MV.A scalable device-less biomaterial approach for subcutaneous islet transplantation.Biomaterials 2021; 269:120499.

[5]	Coronel MM, Linderman SW, Martin KE, Hunckler MD, Medina JD, Barber G, et al.Delayed graft rejection in autoimmune islet transplantation via biomaterial immunotherapy.Am J Transplant 2023; 23(11):1709-1722.

[6]	Campa-Carranza JN, Capuani S, Joubert AL, Hernandez N, Bo T, Sauceda-Villanueva OI, et al.Immune and angiogenic profiling of mesenchymal stem cell functions in a subcutaneous microenvironment for allogeneic Islet transplantation.Adv Sci 2025; 12(20):2411574.

[7]	Li H, Li D, Wang X, Zeng Z, Pahlavan S, Zhang W, et al.Progress in biomaterials-enhanced vascularization by modulating physical properties.ACS Biomater Sci Eng 2024; 11(1):33-54.

[8]	Zhao F, Lei B, Li X, Mo Y, Wang R, Chen D, et al.Promoting in vivo early angiogenesis with sub-micrometer strontium-contained bioactive microspheres through modulating macrophage phenotypes.Biomaterials 2018; 178:36-47.

[9]	Peiseler M, Kubes P.More friend than foe: the emerging role of neutrophils in tissue repair.J Clin Invest 2019; 130(7):2629-2639.

[10]	Spiller KL, Nassiri S, Witherel CE, Anfang RR, Ng J, Nakazawa KR, et al.Sequential delivery of immunomodulatory cytokines to facilitate the M1-to-M2 transition of macrophages and enhance vascularization of bone scaffolds.Biomaterials 2015; 37:194-207.

[11]	Wang Z, Zhao F, Xu C, Zhang Q, Ren H, Huang X, et al.Metabolic reprogramming in skin wound healing. Burns.Trauma 2024; 12:tkad047.

[12]	Wang LH, Marfil-Garza BA, Ernst AU, Pawlick RL, Pepper AR, Okada K, et al.Inflammation-induced subcutaneous neovascularization for the long-term survival of encapsulated islets without immunosuppression.Nat Biomed Eng 2023; 8(10):1-19.

[13]	Jin S, Wen J, Zhang Y, Mou P, Luo Z, Cai Y, et al.M2 macrophage-derived exosome-functionalized topological scaffolds regulate the foreign body response and the coupling of angio/osteoclasto/osteogenesis.Acta Biomater 2024; 177:91-106.

[14]	Pepper AR, Gala-Lopez B, Pawlick R, Merani S, Kin T, Shapiro AMJ.A prevascularized subcutaneous device-less site for islet and cellular transplantation.Nat Biotechnol 2015; 33(5):518-523.

[15]	Jahani M, Rezazadeh D, Mohammadi P, Abdolmaleki A, Norooznezhad A, Mansouri K.Regenerative medicine and angiogenesis; challenges and opportunities.Adv Pharm Bull 2020; 10(4):490-501.

[16]	Zhou X, Xu Z, You Y, Yang W, Feng B, Yang Y, et al.Subcutaneous device-free islet transplantation. Front Immunol, 14 (2023), Article 1287182

[17]	Phelps EA, Headen DM, Taylor WR, Thul PMé, García AJ.Vasculogenic bio-synthetic hydrogel for enhancement of pancreatic islet engraftment and function in type 1 diabetes.Biomaterials 2013; 34(19):4602-4611.

[18]	Gong L, Zhang Y, Zhu Y, Lee U, Luo AC, Li X, et al.Rapid generation of functional vascular organoids via simultaneous transcription factor activation of endothelial and mural lineages.Cell Stem Cell 2025;32(8):1200–17.e6.

[19]	Zhao Y, Sun M, Pan Z, Kong W, Hong Z, Zhang W, et al.A novel quantitative angiogenesis assay based on visualized vascular organoid.Angiogenesis 2025; 28(1):10.

[20]	Pan Z, Yao Q, Kong W, Ma X, Tian L, Zhao Y, et al.Generation of iPSC-derived human venous endothelial cells for the modeling of vascular malformations and drug discovery. Cell Stem Cell 2025;32(2):227–45.e9.

[21]	Vlahos AE, Cober N, Sefton MV.Modular tissue engineering for the vascularization of subcutaneously transplanted pancreatic islets.Proc Natl Acad Sci USA 2017; 114(35):9337-9342.

[22]	Li D, Kong W, Hong Y, Zhang W, Sun B, Wang X, et al.Protocol for isolation and transplantation of rat pancreatic islets in the kidney capsule to treat diabetes.STAR Protoc 2025; 6(1):103486.

[23]	Abraham N, Kolipaka T, Pandey G, Negi M, Srinivasarao DA, Srivastava S.Revolutionizing pancreatic islet organoid transplants: improving engraftment and exploring future frontiers.Life Sci 2024; 343:122545.

[24]	Toftdal MS, Grunnet LG, Chen M.Emerging strategies for beta cell encapsulation for type 1 diabetes therapy.Adv Healthc Mater 2024; 12(19):2400185.

[25]	Qi B, Ding Y, Zhang Y, Kou L, Zhao YZ, Yao Q.Biomaterial-assisted strategies to improve islet graft revascularization and transplant outcomes.Biomater Sci 2024; 12(4):821-836.

[26]	Spiller KL, Anfang RR, Spiller KJ, Ng J, Nakazawa KR, Daulton JW, et al.The role of macrophage phenotype in vascularization of tissue engineering scaffolds.Biomaterials 2014; 35(15):4477-4488.

[27]	Tu Z, Chen M, Wang M, Shao Z, Jiang X, Wang K, et al.Engineering bioactive M2 macrophage-polarized anti-inflammatory, antioxidant, and antibacterial scaffolds for rapid angiogenesis and diabetic wound repair.Adv Funct Mater 2021; 31(30):2100924.

[28]	Mahou R, Zhang DKY, Vlahos AE, Sefton MV.Injectable and inherently vascularizing semi-interpenetrating polymer network for delivering cells to the subcutaneous space.Biomaterials 2017; 131:27-35.

[29]	Waduthanthri KD, Kuppan P, Korbutt GS, Pepper AR, Unsworth LD.Molecular retention limitations for prevascularized subcutaneous sites for islet transplantation.Biomacromolecules 2024; 25(3):1439-1447.

[30]	Jeon S, Heo J, Myung N, Shin JY, Kim MK, Kang H.High‐efficiency, prevascularization‐free macroencapsulation system for subcutaneous transplantation of pancreatic Islets for enhanced diabetes treatment.Adv Mater 2024; 36(50):2408329.

[31]	Yitayew MY, Luginina M, Tabrizian M.Advances in the use of biologics and biomaterials toward the improvement of pancreatic islet graft survival in type 1 diabetes.Adv NanoBiomed Res 2024; 4(3):2300097.